medigraphic.com

2005, Number S1

<< Back Next >>

Rev Mex Anest 2005; 28 (S1)

Intraoperative fluid therapy–crystalloid/colloid debate

Boldt J

Language: English
References: 39
Page: 23-28
PDF size: 67.53 Kb.


Text Extraction

INTRODUCTION

Absolute or relative blood volume deficits often occur in the perioperative period. Bleeding may cause absolute volume deficits - vasodilation mediated by vasodilating substances (e.g. anaesthetics) or rewarming is involved in producing relative volume deficits. Fluid deficits can also develop in the abscence of obvious fluid loss secondary to generalized impairment of the endothelial barrier resulting in diffuse ‘capillary leak‘ (e.g. during inflammation).


REFERENCES

  1. Virgilio RW, Rice C, Smith D, et al. Crystalloid vs colloid rescucitation: Is one better? Surg 1979;2:129-135.

  2. Kreimeier U, Peter K. Strategies of volume therapy in sepsis and systemic inflammatory response syndrome. Kid Internat 1998;53 (suppl 64):75-79.

  3. Dawidson I. Fluid resuscitation of shock: current controversies. Crit Care Med 1989;17:1078-1080.

  4. Prough DS, Johnston WE. Fluid restoration in septic shock: no solution yet. Anesth Analg 1989;69:699-704.

  5. Vincent JL. The colloid-crystalloid controversy. Klin Wochensch 1991;69 (suppl XXVI):104-111.

  6. Sibbald WJ. Fluid therapy in sepsis. In: Reinhard K, Eyrich K, Sprung C, eds. Sepsis - current perspectives in pathophysiology and therapy. Update in Intensive Care and Emergency Medicine, Vol 18. Berlin Heidelberg New York: Springer, 1994;266-273.

  7. Edwards JD. A new debate: colloid versus colloid? In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin Heidelberg New York: Springer, 1994:152-164.

  8. Lamke LO, Liljedahl SO. Plasma volume changes after infusion of various plasma expanders. Resuscitation 1976;5:93-98.

  9. Halmajäe H, Dahlqvist M, Walentin F. Artificial colloid in clinical practice - pros and cons. Bailliere‘s Clinical Anaesthesiology 1997:11/1:49-79.

  10. Hillman K, Bishop G, Bristow P. The crystalloid versus colloid controvery: present status. Bailliere‘s Clinical Anaesthesiology 1997:11/1:1-13.

  11. Stein L, Berand J, Morisette M. Pulmonary edema during volume infusion. Circulation 1975;52:483-489.

  12. Funk W, Baldinger V. Microcirculatory perfusion during volume therapy. Anesthesiology 1995;82:975-982.

  13. Wang P, Hauptman JG, Chaudry IH. Hemorrhage produces depression in microvascular blood flow which persist despite fluid resuscitation. Circ Shock 1990;32:307-318.

  14. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001;93:405-409.

  15. Morisaki H, Sibbald WJ. Issues in colloid and transfusion therapy of sepsis. In: Vincent, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin Heidelberg New York: Springer, 1993:357-372.

  16. Boldt J, v Bormann B, Kling D, et al. Colloidosmotic pressure and extravascular lung water after extracorporeal circulation. Herz 1985;10:366-375.

  17. Baldo-Enzi G, Baiocchi MR, Vigna G, et al. Analbuminemia: a natural model of metabolic compensatory systems. J Inher Metab Dis 1987;10:317-322.

  18. Ruttmann TG, James MFM, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyetyhl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998;80:612-616.

  19. Egli GA, Zollinger A, Seifert B, et al. Effects of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Bri J Anaesth 1997;78:684-689.

  20. Wagner BK, D‘Amelio LF. Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids. Part 1. Clin Pharmacol 1993;12:335-346.

  21. Evans PA, Glenn JR, Heptinstall S, et al. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 1998;81:198-292.

  22. Mardel SN, Saunders FM, Allen H, et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998;80:204-207.

  23. de Jonge E, Levi M, Berends F, et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998;79:286-290.

  24. Franz A, Bräunlich P, Gamsjäger T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-1407.

  25. Strauss RG. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion 1981;21:299-309.

  26. Treib J, Haass A, Pindur G, et al. All medium starches are not the same: influence of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996;36:450-455.

  27. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997;78:974-983.

  28. Boldt J, Müller M, Mentges D, et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998;24:28-36.

  29. Shatney CH, Chaudry ICH. Hydroxethylstarch administration does not depress reticuloendothelial function or increase mortality from sepsis. Circ Shock 1984;13:21-22.

  30. Fisher MM, Brady PW. Adverse reactions to plasma volume expanders. Drug Safety 1990;5:86-93.

  31. Allhoff T, Lenhart FP. Severe dextran-induced anaphylayctic/anaphylactoid reaction inspite of hapten prophylaxis. Infusionsther Transfusionsmed 1993;20:301-306.

  32. Laxenaire M, Charpentier C, Feldman L. Reactions anaphylactoides aux subitutes colloidaux du plasma: incidence, facteurs de risque, mecanismes. Ann Fr Anest Reanimat 1994;13:301-310.

  33. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;. 342:248-249.

  34. Cittanova ML, Leblanc I, Legendre Ch, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-1622.

  35. Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 2002;95:544-551.

  36. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.

  37. Vermeulen LC, Ratko MA, Estad BL, et al. A paradigm for consensus - the university hospital consortium guidelines fo the use of albumin, nonprotein colloids, and crystalloid solutions. Arch Intern Med 1995;155:373-379.

  38. Webb AR. Crystalloid or colloid resuscitation. Are we any wiser? Crit Care 1999;3:R25-R28.

  39. Astiz ME, Rackow EC. Crystalloid-colloid controversy revisited. Crit Care Med 1999;27:34-35.




2020     |     www.medigraphic.com